https://globalregenex.com/
Stem Cell Treatment & Autologous Stem Cell Transplant in Delhi, India
Apr 10, 2026 - Global Regenex is a research-focused platform dedicated to consultation, case evaluation, and patient support in the field of regenerative medicine.
stem cell treatmentautologous transplantin delhiindia
https://adisinsight.springer.com/trials/700346983?error=cookies_not_supported&code=9f5808af-183e-453d-a788-c7b145d079b9
Phase 2 Study of Iberdomide Maintenance Therapy Following Autologous Stem Cell Transplant in...
This is a phase II study to determine the feasibility, safety and efficacy of iberdomide maintenance therapy post-ASCT. Iberdomide will be dosed at 1.0 mg PO
https://pubmed.ncbi.nlm.nih.gov/25641430/
A new "age" for high dose therapy and autologous stem cell transplant
A new "age" for high dose therapy and autologous stem cell transplant
a new agehigh dose
https://profiles.uchicago.edu/profiles/display/5673917
A new "age" for high dose therapy and autologous stem cell transplant. | Profiles RNS
a new age
https://ec2-3-220-198-172.compute-1.amazonaws.com/blood-2024027342-multiple-myeloma/
Salvage autologous transplant in relapsed multiple myeloma: long-term follow-up of the phase 3 GMMG...
May 16, 2025 - Is the need to transplant declining? Salvage autologous transplant vs lenalidomide/dexamethasone offers no significant survival benefit in RRMM. Patients who...
https://profiles.wustl.edu/en/publications/the-efficacy-of-salvage-autologous-stem-cell-transplant-among-pat/fingerprints/?sortBy=alphabetically
The efficacy of salvage autologous stem cell transplant among patients with multiple myeloma who...
https://adisinsight.springer.com/trials/700053992?error=cookies_not_supported&code=1fb2d686-669e-4ef6-bd78-d68f5c78a908
A Trial of Single Autologous Transplant With or Without Consolidation Therapy Versus Tandem...
This randomized trial is investigating the three treatment strategies after a single autologous transplant for patients with multiple myeloma (MM): second